PLAINSBORO, N.J., Jan. 08, 2019 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary fourth quarter 2018 financial results. The company expects reported revenue for the fourth quarter of 2018 to be at the higher end of its previous guidance range of $378 million to $383 …